NCT02161679 Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT02156336 Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP) Status TERMINATED Phase PHASE4
NCT02149888 PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 Status COMPLETED Phase PHASE4
NCT02147834 Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents Status TERMINATED Phase PHASE2
NCT02147067 Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA) Status COMPLETED Phase PHASE2
NCT02136511 Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic Leukemia Status APPROVED_FOR_MARKETING Phase N/A
NCT02135614 Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection Status COMPLETED Phase PHASE2
NCT02135133 A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL Status COMPLETED Phase PHASE2
NCT02133352 Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction Status COMPLETED Phase PHASE4
NCT02128542 Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis Status COMPLETED Phase PHASE4
NCT02121795 Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF Status COMPLETED Phase PHASE3
NCT02120300 Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders Status COMPLETED Phase PHASE2
NCT02104700 Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir Status COMPLETED Phase PHASE2/PHASE3
NCT02104583 Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator Status COMPLETED Phase PHASE2
NCT02081469 Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy Status COMPLETED Phase PHASE4
NCT02081079 Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection Status COMPLETED Phase PHASE2
NCT02077465 Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE1
NCT02074514 Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection Status COMPLETED Phase PHASE3